Signature Equity Partners’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$152 Sell
1
-595
-100% -$99.1K ﹤0.01% 1545
2026
Q1
$125K Sell
596
-637
-52% -$160K 0.07% 250
2025
Q4
$350K Buy
+1,233
New +$386K 0.19% 107

Other funds holding PODD

Signature Equity Partners's PODD Position: Q2 2026 in Review

Signature Equity Partners reduced its Insulet (PODD) stake by 100% in Q2 2026, selling an estimated $99.1K and leaving 1 share worth $152. The position accounts for ﹤0.01% of the portfolio, ranked #1545.

Signature Equity Partners first reported a position in PODD in Q4 2025 and has held it in 3 quarters since. The position peaked at $350K in Q4 2025. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Signature Equity Partners held 1 share of Insulet worth $152 as of Q2 2026.
  • Signature Equity Partners sold 595 Insulet shares in Q2 2026, an estimated $99.1K.
  • Insulet made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #1545 holding.
  • Signature Equity Partners first reported a position in Insulet in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's Insulet position peaked at $350K in Q4 2025.
  • 720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.